Abstract
Fit volunteers were given three doses of 1.5 μg./kg. of the bases of scopolamine or atropine intravenously over a period of 20 minutes. Heart rates fell at first, then rose greater after scopolamine than atropine. Within 30 minutes after the third dose of scopolamine, a striking secondary bradycardia developed, which lasted for three hours. Secondary bradycardia was not seen after atropine. In one experiment with scopolamine, cardiac output was measured and peripheral vascular resistance was calculated. Output varied directly, and resistance inversely in proportion to heart rate.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
